XML 75 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Jul. 31, 2023
Grant Date Fair Value Assumptions [Abstract]        
Share-based compensation $ 19,582,000 $ 14,879,000 $ 15,187,000  
Recognized tax benefits $ (6,700,000) $ (10,800,000) $ (30,000,000)  
Stock Options [Member]        
Stock option activity [Roll Forward]        
Beginning balance (in shares) 642,925      
Granted (in shares) 33,408      
Exercised (in shares) 90,439 71,737 274,253  
Forfeited (in shares) 15,172      
Ending balance (in shares) 570,722 642,925    
Exercisable (In Shares) 371,551      
Stock option weighted average exercise price [Abstract]        
Beginning balance (in dollars per share) $ 154.57      
Granted (in dollars per share) 357.52      
Exercised (in dollars per share) 92.52      
Forfeited (in dollars per share) 293.44      
Ending balance (in dollars per share) 173.13 $ 154.57    
Exercisable at end of period (in dollars per share) $ 102.10      
Weighted Average Remaining Contractual Term [Abstract]        
Weighted average remaining contractual term of shares outstanding (in years) 4 years 2 months 19 days      
Weighted average remaining contractual term of shares exercisable at end of period (in years) 2 years 5 months 23 days      
Aggregate Intrinsic Value [Abstract]        
Ending balance $ 129,309,839      
Exercisable at end of period $ 110,210,899      
Cash Proceeds and Tax Benefits [Abstract]        
Exercised (in shares) 90,439 71,737 274,253  
Cash proceeds $ 8,368,000 $ 6,247,000 $ 14,435,000  
Intrinsic value of options exercised 23,356,000 21,976,000 118,305,000  
Tax benefits realized $ 5,839,000 $ 5,494,000 $ 29,576,000  
Grant Date Fair Value Assumptions [Abstract]        
Expected volatility (in hundredths) 31.00% 28.90% 27.00%  
Expected term (in years) 7 years 4 months 24 days 7 years 1 month 6 days 6 years 10 months 24 days  
Risk-free interest rate (in hundredths) 4.01% 2.92% 1.00%  
Expected dividend yield (in hundredths) 1.15% 1.15% 1.15%  
Grant date fair value (in dollars per share) $ 130.74 $ 116.56 $ 83.05  
Share-based compensation $ 4,618,000 $ 3,413,000 $ 2,846,000  
Recognized tax benefits 1,154,000 853,000 712,000  
Unamortized compensation expense $ 8,100,000      
Expense recognition over weighted average period (in years) 2 years 9 months 18 days      
Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award performance period 3 years      
Shares available for grant 853,337      
Grant Date Fair Value Assumptions [Abstract]        
Share-based compensation $ 14,487,000 $ 11,024,000 $ 11,543,000  
Unamortized compensation expense $ 23,000,000      
Expense recognition over weighted average period (in years) 2 years 4 months 24 days      
Restricted stock awards [Roll Forward]        
Beginning balance (in shares) 212,717      
Granted (at market price) (in shares) 55,196      
Vested (in shares) 58,705 78,931 69,069  
Forfeited (in shares) 5,571      
Ending balance (in shares) 203,637 212,717    
Restricted stock awards weighted average grant date fair value [Abstract]        
Beginning balance (in dollars per share) $ 256.97      
Granted (at market price) (in dollars per share) 357.96      
Vested (in dollars per share) 172.24      
Forfeited (in dollars per share) 326.45      
Ending balance (in dollars per share) $ 306.79 $ 256.97    
Vested (in shares) 58,705 78,931 69,069  
Fair value of restricted stock awards vested $ 20,906,000 $ 37,258,000 $ 24,005,000  
ESPP Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares purchased under the ESPP (in shares) 7,640 7,658 8,649  
Grant Date Fair Value of most recent ESPP Purchase (per share)       $ 57.71
Grant Date Fair Value Assumptions [Abstract]        
Share-based compensation $ 500,000 $ 500,000 $ 800,000  
LTIP 2007 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares allocated for issuance (in shares) 9,315,000      
Shares available for grant 3,947,708      
Employee Stock Purchase Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares allocated for issuance (in shares) 956,250      
Discounted percentage rate offered under the employee stock purchase plan (in hundredths) 85.00%      
Minimum [Member] | Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award performance period, extension period 1 year      
Maximum [Member] | Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award performance period, extension period 2 years